Marker Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.81 +0.05 (+2.84%) USD | NASDAQ | Jan 16, 16:00

1.80 -0.01 (-0.55%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Viridian Therapeutics, Inc.	--
ADMA Biologics, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--
AIM ImmunoTech, Inc.	--